Eleven Therapeutics: Funding, Investors & Team (Sep 2026)
Eleven Therapeutics is a biotechnology company based in Israel.
Eleven Therapeutics has raised $22.0M across 1 funding round on record, the most recent a Seed of $22.0M announced in Aug 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eleven Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Eleven Therapeutics Funding Rounds
Eleven Therapeutics Founders and Leadership Team
Contact details for the Eleven Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Eleven Therapeutics Funding Compared to Other Biotechnology Startups
Eleven Therapeutics' latest round of $22.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eleven Therapeutics in Biotechnology and Tel Aviv
Companies Similar to Eleven Therapeutics
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Eleven Therapeutics Funding FAQs
What does Eleven Therapeutics do?
Eleven Therapeutics is a biotechnology company based in Israel.
How much funding has Eleven Therapeutics raised?
Eleven Therapeutics has raised $22.0M across 1 round on record. The most recent is a Seed of $22.0M announced in Aug 2022.
When did Eleven Therapeutics last raise funding?
Eleven Therapeutics' most recent funding round on record is a Seed of $22.0M, announced in Aug 2022.
Who founded Eleven Therapeutics?
FundedIQ lists Shaul Ilan (Founder) at Eleven Therapeutics.
Where is Eleven Therapeutics headquartered?
Eleven Therapeutics is based in Tel Aviv, Israel.
How many employees does Eleven Therapeutics have?
Eleven Therapeutics is in the 11-50 employee band.
How does Eleven Therapeutics' funding compare to other Biotechnology startups?
Eleven Therapeutics' latest round of $22.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Eleven Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eleven Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.